Chronic  ||| S:0 E:8 ||| JJ
migraine ||| S:8 E:16 ||| NN
:  ||| S:16 E:18 ||| :
pathophysiology  ||| S:18 E:34 ||| FW
Chronic  ||| S:34 E:42 ||| FW
migraine  ||| S:42 E:51 ||| FW
is  ||| S:51 E:54 ||| VBZ
considered  ||| S:54 E:65 ||| VBN
a  ||| S:65 E:67 ||| DT
complication  ||| S:67 E:80 ||| NN
of  ||| S:80 E:83 ||| IN
episodic  ||| S:83 E:92 ||| JJ
migraine ||| S:92 E:100 ||| NN
.  ||| S:100 E:102 ||| .
Several  ||| S:102 E:110 ||| JJ
risk  ||| S:110 E:115 ||| NN
factors ||| S:115 E:122 ||| NNS
,  ||| S:122 E:124 ||| ,
which  ||| S:124 E:130 ||| WDT
may  ||| S:130 E:134 ||| MD
be  ||| S:134 E:137 ||| VB
modifiable  ||| S:137 E:148 ||| NNS
or  ||| S:148 E:151 ||| CC
non-modifiable ||| S:151 E:165 ||| JJ
,  ||| S:165 E:167 ||| ,
make  ||| S:167 E:172 ||| VBP
varying  ||| S:172 E:180 ||| VBG
contributions  ||| S:180 E:194 ||| NNS
to  ||| S:194 E:197 ||| TO
the  ||| S:197 E:201 ||| DT
progression  ||| S:201 E:213 ||| NN
towards  ||| S:213 E:221 ||| IN
chronification ||| S:221 E:235 ||| NN
.  ||| S:235 E:237 ||| .
Every  ||| S:237 E:243 ||| DT
year  ||| S:243 E:248 ||| NN
2.5 ||| S:248 E:251 ||| CD
%  ||| S:251 E:253 ||| NN
of  ||| S:253 E:256 ||| IN
patients  ||| S:256 E:265 ||| NNS
with  ||| S:265 E:270 ||| IN
episodic  ||| S:270 E:279 ||| JJ
migraine  ||| S:279 E:288 ||| NNS
go  ||| S:288 E:291 ||| VBP
on  ||| S:291 E:294 ||| RP
to  ||| S:294 E:297 ||| TO
suffer  ||| S:297 E:304 ||| VB
chronic  ||| S:304 E:312 ||| JJ
migraine ||| S:312 E:320 ||| NN
.  ||| S:320 E:322 ||| .
Experimental  ||| S:322 E:335 ||| JJ
studies  ||| S:335 E:343 ||| NNS
point  ||| S:343 E:349 ||| VBP
to  ||| S:349 E:352 ||| TO
a  ||| S:352 E:354 ||| DT
dysfunction  ||| S:354 E:366 ||| NN
in  ||| S:366 E:369 ||| IN
the  ||| S:369 E:373 ||| DT
descending  ||| S:373 E:384 ||| JJ
pain  ||| S:384 E:389 ||| NN
modulatory  ||| S:389 E:400 ||| NN
system  ||| S:400 E:407 ||| NN
that  ||| S:407 E:412 ||| WDT
would  ||| S:412 E:418 ||| MD
facilitate  ||| S:418 E:429 ||| VB
nociceptive  ||| S:429 E:441 ||| JJ
afferents ||| S:441 E:450 ||| NN
,  ||| S:450 E:452 ||| ,
in  ||| S:452 E:455 ||| IN
the  ||| S:455 E:459 ||| DT
absence  ||| S:459 E:467 ||| NN
of  ||| S:467 E:470 ||| IN
damage  ||| S:470 E:477 ||| NN
to  ||| S:477 E:480 ||| TO
tissues ||| S:480 E:487 ||| NNS
,  ||| S:487 E:489 ||| ,
and  ||| S:489 E:493 ||| CC
so  ||| S:493 E:496 ||| RB
chronic  ||| S:496 E:504 ||| JJ
migraine  ||| S:504 E:513 ||| NN
would  ||| S:513 E:519 ||| MD
share  ||| S:519 E:525 ||| VB
a  ||| S:525 E:527 ||| DT
pathogenesis  ||| S:527 E:540 ||| NN
that  ||| S:540 E:545 ||| WDT
is  ||| S:545 E:548 ||| VBZ
similar  ||| S:548 E:556 ||| JJ
to  ||| S:556 E:559 ||| TO
that  ||| S:559 E:564 ||| DT
of  ||| S:564 E:567 ||| IN
fibromyalgia ||| S:567 E:579 ||| NN
,  ||| S:579 E:581 ||| ,
irritable  ||| S:581 E:591 ||| JJ
bowel  ||| S:591 E:597 ||| JJ
syndrome  ||| S:597 E:606 ||| NN
or  ||| S:606 E:609 ||| CC
chronic  ||| S:609 E:617 ||| JJ
tension-type  ||| S:617 E:630 ||| JJ
headache  ||| S:630 E:639 ||| NN
( ||| S:639 E:640 ||| -LRB-
conditions  ||| S:640 E:651 ||| NNS
that  ||| S:651 E:656 ||| WDT
frequently  ||| S:656 E:667 ||| RB
coexist ||| S:667 E:674 ||| CD
) ||| S:674 E:675 ||| -RRB-
.  ||| S:675 E:677 ||| .
This  ||| S:677 E:682 ||| DT
paper  ||| S:682 E:688 ||| NN
reviews  ||| S:688 E:696 ||| VBZ
the  ||| S:696 E:700 ||| DT
risk  ||| S:700 E:705 ||| NN
factors  ||| S:705 E:713 ||| NNS
and  ||| S:713 E:717 ||| CC
the  ||| S:717 E:721 ||| DT
scientific  ||| S:721 E:732 ||| JJ
evidence  ||| S:732 E:741 ||| NN
of  ||| S:741 E:744 ||| IN
the  ||| S:744 E:748 ||| DT
possible  ||| S:748 E:757 ||| JJ
pathogenic  ||| S:757 E:768 ||| JJ
mechanisms  ||| S:768 E:779 ||| NNS
involved  ||| S:779 E:788 ||| VBN
in  ||| S:788 E:791 ||| IN
the  ||| S:791 E:795 ||| DT
progression  ||| S:795 E:807 ||| NN
towards  ||| S:807 E:815 ||| IN
chronification ||| S:815 E:829 ||| NN
.  ||| S:829 E:831 ||| .
